Finance

Lists
4583:TYO
Chiome Bioscience Inc
100,00 JP¥
-1,96%
(-2,00) 1D
5-окт., 09:14:20 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4583...
Open
100 JP¥
High
100 JP¥
Low
98 JP¥
Mkt. cap
8,19 млд
Avg. vol.
2,50 млн
Volume
142,60 миң
52-wk high
142 JP¥
52-wk low
65 JP¥
EPS
-13 JP¥
Shares outstanding
26,78 млн
No. of employees
49
Open
100 JP¥
High
100 JP¥
Low
98 JP¥
Mkt. cap
8,19 млд
Avg. vol.
2,50 млн
Volume
142,60 миң
52-wk high
142 JP¥
52-wk low
65 JP¥
EPS
-13 JP¥
Shares outstanding
26,78 млн
No. of employees
49
News stories
From web sources and news partners
About Chiome Bioscience Inc
CEO-
Employees49
Founded2005-ж., 8-фев.
Headquarters-
SectorHealth care
Websitechiome.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
118,02 млн
223,48 млн
147,16 млн
126,50 млн
Cost of goods sold
52,72 млн
72,06 млн
66,64 млн
48,50 млн
Cost of revenue
52,72 млн
72,06 млн
66,64 млн
48,50 млн
Research and development expenses
190,33 млн
190,34 млн
174,47 млн
194,51 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
143,50 млн
135,51 млн
138,40 млн
130,86 млн
Operating expense
333,83 млн
325,84 млн
312,87 млн
325,37 млн
Total operating expenses
386,54 млн
397,90 млн
379,51 млн
373,87 млн
Operating income
-268,52 млн
-174,43 млн
-232,34 млн
-247,37 млн
Other non operating income
-109,00 миң
-7,02 млн
-980,00 миң
-1,76 млн
EBT including unusual items
-259,15 млн
-181,72 млн
-232,34 млн
-249,28 млн
EBT excluding unusual items
-268,39 млн
-181,72 млн
-232,34 млн
-249,28 млн
Income tax expense
810,00 миң
810,00 миң
810,00 миң
810,00 миң
Effective tax rate
-0,31%
-0,45%
-0,35%
-0,32%
Other operating expenses
-
-
-
-
Net income
-259,96 млн
-182,53 млн
-233,15 млн
-250,09 млн
Net profit margin
-220,27%
-81,68%
-158,43%
-197,71%
Earnings per share
-
-
-
-
Interest and investment income
1,42 млн
126,00 миң
1,03 млн
123,00 миң
Interest expense
-959,00 миң
-256,00 миң
-292,00 миң
-313,00 миң
Net interest expenses
463,00 миң
-130,00 миң
739,00 миң
-190,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-268,23 млн
-173,49 млн
-231,41 млн
-244,96 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору